Abstract
Clinical trial reports do more than just present findings; they also influence how we think about what counts as innovation. In this study, we looked at how clinical trials are described across Africa and Europe, focusing on how often language linked to innovation is used compared to more evaluative terms. Using a semantic approach, we reviewed interventional studies to see how words like “novel” or “breakthrough” appear alongside terms such as “safety” and “efficacy.”
What became clear is that studies from African settings tend to place more emphasis on feasibility and practical application, while European studies more often highlight novelty. In contexts like Uganda, this makes sense because research is often shaped by immediate health system needs. At the same time, this difference in how studies are described may affect how research from different regions is perceived globally.
conclusively, the findings suggest that how research is communicated is as important as the research itself, especially for recognition and visibility.
References
Nabyonga-Orem, J., et al. (2021). "The state of health research governance in Africa: what do we know and how can we improve?" Health Research Policy and Systems 19(1): 11.
2. , J.-A., et al. (2013). "Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?" The Lancet 382(9900): 1286-1307.
3. Viergever, R. F. and K. Li (2015). "Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013." BMJ open 5(9): e008932.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Agnes Kindiki, Tibamwenda Christopher, Muruhukye Jacob, Kindiki Agnes, Nabateregga Prossy, Eyong Peter Ebot
